Evidence map›Paper›PMID 25144566›Full record

ArticlePloS one2014

Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy.

Asha R Kallianpur, Peilin Jia, Ronald J Ellis, Zhongming Zhao, Cinnamon Bloss, Wanqing Wen, Christina M Marra, Todd Hulgan, David M Simpson, Susan Morgello and 13 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. HIV-related Neuropathy: Pathophysiology, Treatment and Challenges.Journal of neurology and experimental neuroscience · 2021
    Article
  11. Article
  12. Observational
  13. Article
  14. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2017
    Observational
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 11 institutions in 1 country.

Asha R KallianpurDepartment of Genomic Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, United States of America.
Peilin JiaDepartment of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Ronald J EllisDepartment of Neurology, University of California San Diego, San Diego, California, United States of America.
Zhongming ZhaoDepartment of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Cinnamon BlossScripps Genomic Medicine, Scripps Translational Science Institute, and Scripps Health, La Jolla, California, United States of America.
Wanqing WenDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Christina M MarraDepartment of Neurology, University of Washington, Seattle, Washington, United States of America.
Todd HulganDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
David M SimpsonDepartment of Neurology, Icahn School of Medicine of Mt. Sinai, New York, New York, United States of America.
Susan MorgelloDepartment of Neurology, Icahn School of Medicine of Mt. Sinai, New York, New York, United States of America.
Justin C McArthurDepartment of Neurology, Johns Hopkins University, Baltimore, Maryland, United States of America.
David B CliffordDepartment of Neurology, Washington University, St. Louis, Missouri, United States of America.
Ann C CollierDepartment of Medicine, University of Washington, Seattle, Washington, United States of America.
Benjamin B GelmanDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
J Allen McCutchanDepartment of Medicine, University of California San Diego, San Diego, California, United States of America.
Donald FranklinHIV Neurobehavioral Research Center & CHARTER Center, University of California San Diego, San Diego, California, United States of America.
David C SamuelsDepartment of Molecular Physiology and Biophysics and Center for Human Genetics Research, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Debralee RosarioHIV Neurobehavioral Research Center & CHARTER Center, University of California San Diego, San Diego, California, United States of America.
Emily HolzingerDepartment of Molecular Physiology and Biophysics and Center for Human Genetics Research, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Deborah G MurdockDepartment of Molecular Physiology and Biophysics and Center for Human Genetics Research, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Scott LetendreDepartment of Medicine, University of California San Diego, San Diego, California, United States of America.
Igor GrantDepartment of Psychiatry, University of California San Diego, San Diego, California, United States of America.
CHARTER Study Group
Vanderbilt University · USUniversity of California, San Diego · USCenter for Human Genetics · USIcahn School of Medicine at Mount Sinai · USNeurobehavioral Research (United States) · USUniversity of Washington · USCase Western Reserve University · USJohns Hopkins University · USScripps Health · USThe University of Texas Medical Branch at Galveston · USWashington University in St. Louis · US

Funding

Therapeutic CoreP30MH075673 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Leah Helane Rubin, Barbara Stauch Slusher · 2006 to 2026
$33.2M
CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS RESEARCH (CHARTER)N01MH22005 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 2007 to 2009
$12.0M
Genetic Epidemiology of Complex TraitsZIAHG200327 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BAILEY-WILSON, JOAN ELLEN · 2009 to 2022
$10.5M
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER StudyR01MH095621 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HULGAN, TODD M, KALLIANPUR, ASHA R · 2011 to 2015
$3.1M
CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS RESEARCH /CHARTER/ -278022005-278022005N01MH022005 · NIMH · UNIVERSITY OF CA -SAN DIEGO · PI GRANT, IGOR · 2003 to 2006
–
NIMH NIH HHS 1R01 MH 095621NIMH NIH HHS HHSN271201000036CNIMH NIH HHS N01 MH022005NIMH NIH HHS N01 MH22005NIMH NIH HHS P30 MH075673NIMH NIH HHS R01 MH095621
6 · The paper itself

Abstract

HIV sensory neuropathy and distal neuropathic pain (DNP) are common, disabling complications associated with combination antiretroviral therapy (cART). We previously associated iron-regulatory genetic polymorphisms with a reduced risk of HIV sensory neuropathy during more neurotoxic types of cART. We here evaluated the impact of polymorphisms in 19 iron-regulatory genes on DNP in 560 HIV-infected subjects from a prospective, observational study, who underwent neurological examinations to ascertain peripheral neuropathy and structured interviews to ascertain DNP. Genotype-DNP associations were explored by logistic regression and permutation-based analytical methods. Among 559 evaluable subjects, 331 (59%) developed HIV-SN, and 168 (30%) reported DNP. Fifteen polymorphisms in 8 genes (p<0.05) and 5 variants in 4 genes (p<0.01) were nominally associated with DNP: polymorphisms in TF, TFRC, BMP6, ACO1, SLC11A2, and FXN conferred reduced risk (adjusted odds ratios [ORs] ranging from 0.2 to 0.7, all p<0.05); other variants in TF, CP, ACO1, BMP6, and B2M conferred increased risk (ORs ranging from 1.3 to 3.1, all p<0.05). Risks associated with some variants were statistically significant either in black or white subgroups but were consistent in direction. ACO1 rs2026739 remained significantly associated with DNP in whites (permutation p<0.0001) after correction for multiple tests. Several of the same iron-regulatory-gene polymorphisms, including ACO1 rs2026739, were also associated with severity of DNP (all p<0.05). Common polymorphisms in iron-management genes are associated with DNP and with DNP severity in HIV-infected persons receiving cART. Consistent risk estimates across population subgroups and persistence of the ACO1 rs2026739 association after adjustment for multiple testing suggest that genetic variation in iron-regulation and transport modulates susceptibility to DNP.

Indexed as

AdultAgedAnti-Retroviral AgentsFemaleGenetic VariationGenotypeHIV InfectionsHumansIronIron Regulatory Protein 1Linkage DisequilibriumMaleMiddle AgedMultivariate AnalysisNeuralgiaYoung AdultAnti-Retroviral AgentsIronIron Regulatory Protein 1

Identifiers

PMID25144566
PMCPMC4140681
OpenAlexW2143803988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.